The prevalence of diabetes mellitus (DM) continues to increase among patients undergoing total hip arthroplasty (THA). It is unclear how insulin use is correlated with risk for adverse outcomes.
Methods:
A cohort of 146,526 patients undergoing primary THA were identified in the 2005–2017 National Surgical Quality Improvement Program database. Patients were classified as insulin-dependent diabetic (IDDM), non-insulin-dependent diabetic (NIDDM), or not diabetic. Multivariate analyses were used.
Results:
Compared to patients without diabetes, patients with NIDDM were at increased risk for 4 of 17 perioperative adverse outcomes studied. Patients with IDDM were at increased risk for those 4 and 8 additional adverse outcomes (12 of the 17 studied).
Conclusion:
These findings have important implications for preoperative risk stratification and quality improvement initiatives.
SloanMPremkumarAShethNP.Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am2018; 100: 1455–1460.
3.
SchettGKleyerAPerriconeC, et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care2013; 36: 403–409.
4.
ShohatNGoswamiKTarabichiM, et al. All patients should be screened for diabetes before total joint arthroplasty. J Arthroplasty2018; 33: 2057–2061.
5.
LenguerrandEWhitehouseMRBeswickAD, et al. Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales. Lancet Infect Dis2019; 19: 589–600.
6.
MartinETKayeKSKnottC, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol2016; 37: 88–99.
7.
RichardsJEKauffmannRMZuckermanSL, et al. Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am2012; 94: 1181–1186.
8.
ChristABChiuYFJosephA, et al. Risk factors for peripheral nerve injury after 207,000 total hip arthroplasties using a New York state database (Statewide Planning and Research Cooperative System). J Arthroplasty2019; 34: 1787–1792.
9.
MarchantMHJrViensNACookC, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am2009; 91: 1621–1629.
10.
LovecchioFBealMKwasnyM, et al. Do patients with insulin-dependent and noninsulin-dependent diabetes have different risks for complications after arthroplasty?Clin Orthop Relat Res2014; 472: 3570–3575.
11.
LeeDLeeRGowdaNB, et al. Impact of diabetes mellitus on surgical complications in patients undergoing revision total knee arthroplasty: insulin dependence makes a difference. J Clin Orthop Trauma2020; 11: 140–146.
12.
PhanKKimJSLeeN, et al. Impact of insulin dependence on perioperative outcomes following anterior cervical discectomy and fusion. Spine (Phila Pa 1976)2017; 42: 456–464.
13.
GolinvauxNSVarthiAGBohlDD, et al. Complication rates following elective lumbar fusion in patients with diabetes: insulin dependence makes the difference. Spine (Phila Pa 1976)2014; 39: 1809–1816.
14.
D’HooreWBouckaertATilquinC.Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol1996; 49: 1429–1433.
15.
SundararajanVHendersonTPerryC, et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol2004; 57: 1288–1294.
16.
JørgensenCCMadsbadSKehletH, et al. Postoperative morbidity and mortality in type-2 diabetics after fast-track primary total hip and knee arthroplasty. Anesth Analg2015; 120: 230–238.
17.
TsangSTGastonP.Adverse peri-operative outcomes following elective total hip replacement in diabetes mellitus: a systematic review and meta-analysis of cohort studies. Bone Joint J2013; 95–B: 1474–1479.
18.
WebbMLGolinvauxNSIbeIK, et al. Comparison of perioperative adverse event rates after total knee arthroplasty in patients with diabetes: insulin dependence makes a difference. J Arthroplasty2017; 32: 2947–2951.
19.
CapozziJDLepkowskyERCallariMM, et al. The prevalence of diabetes mellitus and routine hemoglobin A1c screening in elective total joint arthroplasty patients. J Arthroplasty2017; 32: 304–308.
20.
CancienneJMWernerBCBrowneJA.Is there a threshold value of hemoglobin A1c that predicts risk of infection following primary total hip arthroplasty?J Arthroplasty2017; 32: S236–S240.
21.
TarabichiMShohatNKheirMM, et al. Determining the threshold for HbA1c as a predictor for adverse outcomes after total joint arthroplasty: a multicenter, retrospective study. J Arthroplasty2017; 32: S263–S267.e1.
22.
CitakMToussaintBAbdelazizH, et al. Elevated HbA1c is not a risk factor for wound complications following total joint arthroplasty: a prospective study. Hip Int2020; 30(Suppl. 1): 19–25.
23.
ShohatNTarabichiMTanTL, et al. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study. Bone Joint J2019; 101–B(Suppl. C): 3–9.
24.
ChrastilJAndersonMBStevensV, et al. Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty?J Arthroplasty2015; 30: 1197–1202.
25.
GodshawBMOjardCAAdamsTM, et al. Preoperative glycemic control predicts perioperative serum glucose levels in patients undergoing total joint arthroplasty. J Arthroplasty2018; 33: S76–S80.
26.
GodshawBMWarrenMSNammourMA, et al. Insulin-dependent diabetic patients are at increased risk of postoperative hyperglycemia when undergoing total joint arthroplasty. J Arthroplasty2020; 35: 2375–2379.
27.
ShohatNMuhsenKGilatR, et al. Inadequate glycemic control is associated with increased surgical site infection in total joint arthroplasty: a systematic review and meta-analysis. J Arthroplasty2018; 33: 2312–2321.e3.
28.
KheirMMTanTLKheirM, et al. Postoperative blood glucose levels predict infection after total joint arthroplasty. J Bone Joint Surg Am2018; 100: 1423–1431.
29.
ReáteguiDTorneroEPopescuD, et al. Postoperative hyperglycaemia control reduces postoperative complications in patients subject to total knee arthroplasty. Knee2017; 24: 128–136.
30.
WangSHXuCTanTL, et al. Increased postoperative glucose variability is associated with adverse outcome following two-stage exchange arthroplasty for periprosthetic joint infection. J Arthroplasty2020; 35: 1368–1373.
31.
GuAWeiCRobinsonHN, et al. Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty. J Knee Surg2020; 33: 228–234.
32.
O’ToolePMaltenfortMGChenAF, et al. Projected increase in periprosthetic joint infections secondary to rise in diabetes and obesity. J Arthroplasty2016; 31: 7–10.
33.
DuensingIAndersonMBMeeksHD, et al. Patients with type-1 diabetes are at greater risk of periprosthetic joint infection: a population-based, retrospective, cohort study. J Bone Joint Surg Am2019; 101: 1860–1867.
34.
Maradit KremersHSchleckCDLewallenEA, et al. Diabetes mellitus and hyperglycemia and the risk of aseptic loosening in total joint arthroplasty. J Arthroplasty2017; 32: S251–25S3.
35.
SelemonNAGuAMalahiasMA, et al. Insulin-dependent diabetes mellitus is an independent risk factor for postoperative complications in aseptic revision total hip arthroplasty. Hip Int. Epub ahead of print 4 August 2020. DOI: 10.1177/1120700020945221.
